4
Changes in Ownership
BeOne Medicines Ltd. Filed Acc 0001104659-17-010630
Chief Executive Officer sold 64,963 shares at an average $40.55 ($2,634,011)
From the SEC's structured data for this filing
Trades in this filing
OYLER JOHN · Chief Executive Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-02-16 | Sale : show line 1 in the form | −9,057 | $40.23 | $364,379 | 378,383 | D |
| 2017-02-16 | Sale : show line 2 in the form | −38,343 | $40.75 | $1,562,489 | 340,040 | D |
| 2017-02-17 | Sale : show line 3 in the form | −7,204 | $40.67 | $292,981 | 332,836 | D |
| 2017-02-21 | Sale : show line 4 in the form | −7,426 | $39.83 | $295,794 | 325,410 | D |
| 2017-02-21 | Sale : show line 5 in the form | −2,933 | $40.36 | $118,369 | 322,477 | D |
| Open-market sales · 64,963 sh · avg $40.55 · $2,634,011 | ||||||
Loading xslF345X03/a4.xml…